Biden Administration Withdraws Azar’s Notice of Appointments to 340B Dispute Resolution Board

There are questions about the legal and practical effects of the administration's action yesterday regarding ex-HHS Secretary Azar's appointments to the new 340B dispute resolution board. | Shutterstock

The Biden administration yesterday withdrew former U.S. Health and Human Services (HHS) Secretary Alex Azar’s Jan. 20 public notice of his appointment of six voting and two ex-officio non-voting members to a new 340B program administrative dispute resolution (ADR)

Read More »

Biden Team Freezes 340B Insulin Rule, to Health Centers’ Relief

Health center leaders worried that the Biden's administration's regulatory freeze memo didn't guarantee that a Trump administration rule regarding the 340B program and insulin that they opposed would definitely be delayed. | Source: Shutterstock

Health centers leaders are applauding the Biden administration’s decision yesterday to push back, from today until March 22, the effective date of the Trump administration’s controversial final rule to require health centers to provide insulin and injectable epinephrine to low-income

Read More »

In Surprise Move, 340B Dispute Resolution Board Members Appointed

In one of his last acts as HHS Secretary, Alex Azar appointed the six voting and two ex-officio non-voting members of the 340B program’s new administrative dispute resolution (ADR) board.

Alex Azar, at 8:45 a.m. Eastern yesterday in one of his last acts as U.S. Health and Human Services (HHS) secretary, appointed the six voting and two ex-officio non-voting members of the 340B program’s new administrative dispute resolution (ADR) board.

Read More »

Pedley’s Promotion May Presage Hiring of a New 340B Program Director

Rear Adm. Krista Pedley’s promotion, and OPA’s new place within the HRSA administrator’s office, are symbolic of the 340B program’s growing importance in prescription drug pricing policy, and reflects how highly regarded Pedley is in HRSA and HHS.

U.S. Public Health Service (PHS) Rear Adm. Krista Pedley, who has led the federal 340B drug pricing program for more than a decade, has been promoted within the U.S. Health Resources and Services Administration (HRSA) in conjunction with a major

Read More »

Biden Appoints Acting Leaders at HRSA, CMS, and HHS

President Biden named HHS career civil servant Norris Cochran to be the acting head of HHS pending a Senate vote on Xavier Becerra's nomination for the post. | Source: C-SPAN

President Biden has accepted the resignation of U.S. Health Resources and Services Administration (HRSA) Administrator Tom Engels, whom former President Trump appointed to the post in November 2019. Diana Espinosa, a career civil servant who has served as HRSA’s deputy

Read More »

Health Centers Scramble to Secure a Freeze on 340B Insulin Rule

The Biden administration caught health center leaders off guard by not explicitly instructing HHS's new leadership to put a Trump administration 340B-related rule on ice. | Source: Shutterstock

Community health center leaders are concerned that the Biden administration yesterday asked, but did not order, the U.S. Health and Human Services Department (HHS) to postpone tomorrow’s scheduled implementation of a controversial Trump administration final rule that will require health

Read More »

House E&C Leaders Announce Leadership Team and New Committee Members

U.S. House Energy & Commerce party leaders recently announced new committee members.

U.S. House Energy and Commerce (E&C) Chair Frank Pallone (D-N.J.) last Friday formally announced Rep. Anna Eshoo (D-Calif.) as Health subcommittee chair and Rep. Diana DeGette (D-Colo.) as leader of the Oversight and Investigations subcommittee.

Eshoo, who is based

Read More »

Our First Issue Behind Our Paywall

340B Report’s content including full articles is now available exclusively for paid subscribers. For those who have already paid, we sincerely thank you. If you have any questions about logging in, please contact Reshma Eggleston at reshma.eggleston@340Breport.com

For those who have not

Read More »

Gilead Adjusts Planned Change in its Patient Assistance After HIV Community Pushes Back

NASTAD and others in the HIV community said they raised their concerns with Gilead about its planned change to its patient assistance program, and the company appears to have listened. | Source: Shutterstock

Drug manufacturer Gilead has altered a planned change to its patient assistance program (PAP) for uninsured people living with HIV that would have been unworkable for some vulnerable patients, HIV/AIDS caregivers and activists say. The change also would have deprived

Read More »

HHS Asks Court to Toss Out Hospitals’ 340B Contract Pharmacy Lawsuit

The lawsuit against HHS by 340B hospitals is just one of several underway over drug manufacturers’ denials of 340B pricing on drugs dispensed by contract pharmacies. | Source: Shutterstock

Outgoing U.S. Health and Human Services (HHS) Secretary Alex Azar last week asked a federal district judge to dismiss a lawsuit against him and his department by 340B hospitals over HHS’s enforcement of its 340B contract pharmacy requirements for drug

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live